Home Our services Syndicated insights & RWE Smart Analyst Smart Analyst Oncology Insights Series

Smart Analyst Oncology Insights Series.

Syndicated reports.

Data-driven insights into the future market dynamics for nearly 40 tumors.

With a forward-looking focus on the clinical landscape,  Smart Analyst Oncology Insights – a syndicated report – is the best way to understand your market opportunity, access detailed clinical data, and receive updates on the changing landscape.

Oncology is the cornerstone of our consulting business, and we have developed the series as a foundation for our clients’ key clinical and commercial development and BD&L decisions.

With the Smart Analyst Oncology Insights, you will:

  • Obtain a forward-looking perspective and expert views on key tumors, in order to shape commercial and clinical decisions for pipeline assets and BD opportunities
  • Stay current, with updates delivered twice each year
  • Understand how the competitive dynamics would impact the treatment paradigm in the coming 2-3 years
  • Acquire comprehensive foundational data with rich clinical data and insights
  • Keep track of the immunotherapy landscape and its impact on strategic decisions on an IO/non-IO in the portfolio
  • Get a global perspective, with insights on the US, EU, and select Asia-Pacific markets
  • Consolidate key insights and data in one concise report – and avoid internal “fire drills” accessing data
  • Quickly get up to speed on a tumor when evaluating a BD&L opportunity
  • Easily cut-and-paste data and slides into your own presentations.

Therapy area planner:

Solid Tumors

Bladder Cancer
Cervical Cancer
Colorectal Cancer
DTC
Endometrial
Esophageal Cancer
Gastric Cancer
GBM
Glioma
HCC
HER2+ Breast Cancer
HER2NegHR+ Breast Cancer

Melanoma
Mesothelioma
MTC
NET
NSCLC
Ovarian Cancer
Pancreatic Cancer
Prostate
RCC
SCCHN
SCLC
TNBC
Hematologic Malignancies 
ALL
AML
CLL
Diffuse-large B-cell Lymphoma
Follicular Lymphoma
HL
MZL
MCL
MDS
Multiple Myeloma
Myelofibrosis
Primary CNS Lymphoma
SLL
Waldenström Macroglobulinemia

Table of contents:

  • Executive summary
  • Disease overview
    Anatomy/Histology, Symptoms/Diagnosis, Staging/Classification
  • Epidemiology
    Treatment starts by line of therapy for 2020-2025
  • Current Treatment Landscape
    Treatment Algorithm, Benchmarks, Timelines: Approvals and Patient Expirations, Unmet Needs, Pricing and Reimbursement
  • Emerging Treatment Landscape
    Clinical Pipeline Activity, Summary of IO Activity, Summary of Key Emerging Agents, Emerging Patient Segments, Current and Emerging Biomarkers
  • Appendix
    Trial Profiles of Emerging Agents, Trial Failures

Find out more.

Request more information about Smart Analyst oncology insights reports.

Our other reports and services.

Experts in syndicated research.

Brendan Langan

Senior Commercial and Strategy Director

About Brendan.

Brendan has over 20 years’ of progressive experience serving as a partner to stakeholders in life sciences, pharmaceutical, biotech and healthcare. His research experience spans all facets of qualitative and quantitative primary market research, competitive intelligence, secondary and syndicated research.

brendan.langan@researchpartnership.com